Skip to main content
See every side of every news story
Published loading...Updated

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) Insider Sells $206,850.00 in Stock

Summary by MarketBeat
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) insider Atul Dandekar sold 7,500 shares of the business's stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $27.58, for a total value of $206,850.00. Following the completion of the sale, the insider directly owned 26,250 shares of the company's stock, valued at approximately $723,975. This trade represents a 22.22% decrease in their position. The…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Monday, August 31, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal